Acne Medication Market Thumbnail Image

2020

Acne Medication Market

Acne Medication Market Size, Share, Competitive Landscape and Trend Analysis Report by Therapeutic Class (Retinoids, Antibiotics, Salicylic Acid, Benzoyl Peroxide, and Others), Formulation (Topical Medications and Oral Medications), Type (Prescription Medicines and Over-The-Counter Medicines), Acne Type (Non-Inflammatory Acne and Inflammatory Acne), and Distribution Channel (Retail Stores, Pharmacies & Drug Stores, and E-Commerce): Global Opportunity Analysis and Industry Forecast, 2019-2027

Select an option
Author's: Trupti Wadekar| Smita Nerkar | Roshan Deshmukh
Publish Date:

Get Sample to Email

The global acne medication market was valued at $11,865.9 million in 2019, and is projected to reach $13,357.57 million by 2027 at a CAGR of 3.80% from 2020 to 2027.

Acne or acne vulgaris is one of the most common skin conditions majorly caused by changes in skin structures. It affects millions of adolescents across the world. It is characterized by pimples, blackheads, oily skin, and scarring. There are two types of acne including non-inflammatory and inflammatory, where the latter takes longer duration to heal and can cause permanent effects on skin. It generally affects skin with comparatively high number of sweat glands such as upper part of chest, back, and face. Acne medications are drugs that are indicated for treatment of acne. These include several prescription and over-the-counter medicines such as retinoids, isotretinoin, antibiotics, salicylic acid, benzoyl peroxide, and oral contraceptives.

Acne-Medication-Market-2020-2027

Increase in prevalence of acne diseases is the major factor that contributes toward growth of the acne medication market. Moreover, other factors that fuel the market include unhealthy urban lifestyle and presence of robust acne medications in pipeline. However, side-effects associated with the use of acne medications and presence of alternative treatment impede the market growth. Conversely, development of effective medications with lesser side effects and high market potential in untapped emerging economies are expected to provide lucrative growth opportunities for the market growth.

The COVID-19 outbreak that started from Wuhan city of China has now wide spread globally. Almost every nation is dealing with the outbreak. The acne medication market is impacted by the pandemic as most countries adopted lockdown to combat the pandemic. This pandemic has disrupted growth in many economies across various domains. The COVID-19 pandemic has stressed healthcare systems worldwide and many dermatology clinics are no longer open for public services, owing to safety. Several hospitals and clinics have been transformed into COVID-19 centers using pandemic-designated hospital structures for treatment and isolation of patients with a COVID-19 infection. Furthermore, owing to lockdown, many patients are not able to visit dermatology clinics and pharmacies to pick up prescriptions. In this pandemic situation factors such as telemedicine has become an appropriate and effective way to offer necessary dermatological services to patients with acne.

The global acne medication market is segmented into therapeutic class, formulation, type, acne type, distribution channel, and region. By therapeutic class, the market is divided into retinoids, antibiotics, salicylic acid, benzoyl peroxide, and others. The retinoids segment is further classified into topical retinoid & combination retinoid and oral retinoid (isotretinoin). Moreover, the antibiotics segment is further sub segmented into topical antibiotics & combination antibiotics and oral antibiotics. On the basis of formulation, the market is bifurcated into topical medication and oral medication. By type, it is divided into prescription medicine and over-the-counter (OTC) medicine. By acne type, it is fragmented into non-inflammatory and inflammatory acne. By distribution channel, it is classified into retail Store, pharmacy & drug store, and e-commerce. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Acne Medication Market
By Therapeutic Class
Your browser does not support the canvas element.

Retinoids segment holds a dominant position in 2019 and would continue to maintain the lead over the forecast period.

Therapeutic Class segment review

By therapeutic class, the retinoids segment accounted for the largest share in 2019. Retinoids are most effective for moderate to severe acne as it unblocks pores, allowing topical creams and gels to work better. Moreover, retinoids decrease post-inflammatory hyper pigmentation, while simultaneously preventing formation of any new acne on the skin. However, the salicylic acid segment is expected to grow at the highest CAGR from 2020 to 2027.

Acne Medication Market
By Formulation
Your browser does not support the canvas element.

Topical Medication Segment is projected as one of the most lucrative segment.

Type segment review

On the basis of type, presently, the prescription medicine segment is the revenue generating segment in the acne medication market. Prescription acne products such as antibiotics are usually combined with benzoyl peroxide or a topical retinoid that makes up for an effective combination, which is anticipated to drive the prescription acne medication market during the forecast period. On the other hand, the over-the-counter medicine segment is anticipated to record a CAGR of 3.20% during the forecast period, owing to rise in preference of patient population who use over-the-counter(OTC) products as they are convenient to purchase and inexpensive in nature, which propels the acne medication market growth.

Acne Medication Market
By Region
2027
North America 
Europe
Asia-Pacific
LAMEA

Asia Pacific region would exhibit the highest CAGR of 4.9% during 2020-2027.

North America accounted for the largest share of revenue in 2019, and is anticipated to maintain its dominance from 2020 to 2027, owing to numerous developments related to acne therapeutics. However, Asia-Pacific is expected to register highest CAGR during the forecast period, owing to increase in number of product launches, high demand for acne therapeutics, and surge in healthcare expenditure as well as growth in awareness related to new developed therapeutics that can replace conventional acne treatment in this region.

Some of the key players operating in the acne medication market include Almirall SA.,Bausch Health Companies Inc., GlaxoSmithKline Plc (GSK), Johnson & Johnson, Galderma S.A, Mayne Pharma Group Limited, Mylan N.V., Pfizer Inc., Sun Pharmaceutical Industries Limited, and Teva Pharmaceutical Industries Ltd.

Key Benefits For Stakeholders

  • This report provides a detailed quantitative analysis of the current acne medication market trends and future estimations from 2020 to 2027, which assists in identifying prevailing acne medication market opportunities. 
  • An in-depth analysis of various regions is likely to provide a detailed understanding of the current trends to the stakeholders to formulate region-specific plans.
  • Comprehensive analysis of factors that drive and restrain growth of the acne medication market are provided.
  • Key regulatory guidelines for the acne medication market are critically dealt according to region.
  • A deep dive analysis of various regions provides insights that would allow companies to strategically plan their business moves.

Acne Medication Market Report Highlights

Aspects Details
Acne Medication Market By Therapeutic Class
By Therapeutic Class
  • Retinoid
    • Topical Retinoid & Combination Retinoid
    • Oral Retinoid (Isotretinoin)
  • Antibiotic
    • Topical Antibiotic & Combination Antibiotics
    • Oral Antibiotics
  • Salicylic Acid
  • Benzoyl Peroxide
  • Other medications
Acne Medication Market By Formulation
By Formulation
  • Topical Medication
  • Oral Medication
Acne Medication Market By Type
By Type
  • Prescription Medicine
  • Over-the-counter medicines
Acne Medication Market By Acne Type
By Acne Type
  • Non-inflammatory acne
  • Inflammatory acne
Acne Medication Market By Distribution Channel
By Distribution Channel
  • Retail Store
  • Pharmacy & Drug Store
  • E-Commerce
Acne Medication Market By Region
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (Germany, France, UK, Italy, Spain, Rest of Europe)
  • Asia-Pacific  (Japan, China, India, Australia, South Korea, Rest of Asia-Pacific)
  • LAMEA  (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Key Market Players
Key Market Players

PFIZER INC., MYLAN N.V., ALMIRALL SA, JOHNSON & JOHNSON, MAYNE PHARMA GROUP LIMITED, TEVA PHARMACEUTICAL INDUSTRIES LTD, GLAXOSMITHKLINE PLC (GSK), GALDERMA S.A., BAUSCH HEALTH COMPANIES INC., SUN PHARMACEUTICAL INDUSTRIES LIMITED

Analyst Review

Acne is a skin disease caused due to the dead skin cells, oil excreted from the skin, and clogged hair follicles. It is most common in teenagers and can continue into adulthood mainly affecting the women. According to various studies, it is estimated that average age of onset of acne is 11 to 15 years, owing to changes in demographics and social habits. Several acne treatment options are developed among which acne medications are employed for treatment of mild to severe acne cases. These medications include topical tretinoin, benzoyl peroxide, adapalene, or salicylic acid, and oral type such as tetracycline, erythromycin, minocycline, doxycycline, clindamycin, and trimethoprim-sulfamethoxazole. Growth in patients suffering from acne vulgaris, especially teenagers, is the major factor that drives growth of the global acne medication market. Other factors such as rise in demand for skin care products and unhealthy urban lifestyle are expected to have a significant impact on growth of the market. However, factors such as side effects associated with acne drugs and presence of alternative treatment options such as laser, hamper the market growth. 

CXOs further added that use of acne medications is the highest in North America, owing to a large patient population and high adoption of prescription-based products, which is followed by Europe and Asia-Pacific. In addition, acne medication providers and distributors are focused on expanding their presence in emerging economies, which, in turn, is anticipated to drive the market growth.
 

Author Name(s) : Trupti Wadekar| Smita Nerkar | Roshan Deshmukh
Frequently Asked Questions?

The total market value of Acne Medication Market is $11,865.9 million in 2019.

The forcast period for Acne Medication Market is 2020 to 2027

The market value of Acne Medication Market in 2020 is $10,318.18 million.

The base year is 2019 in Acne Medication Market

Top companies such as, Almirall SA., Bausch Health Companies Inc., GlaxoSmithKline Plc (GSK), Johnson & Johnson, Galderma S.A, Mayne Pharma Group Limited, Mylan N.V., Pfizer Inc., Sun Pharmaceutical Industries Limited, and Teva Pharmaceutical Industries Ltd.

Retinoids segment is the most influencing segment. Retinoids are most effective for moderate to severe acne as it unblocks pores, allowing topical creams and gels to work better.

The major factor that fuels the growth of the acne medication market includes prevalence of acne diseases, which contributes toward growth of the acne medication market. Moreover, other factors that fuel the market growth include unhealthy urban lifestyle and presence of robust acne medications in pipeline.

No, there is no value chain analysis provided in the Acne Medication Market report

Acne, also known as acne vulgaris, is a long-term skin disease that occurs when dead skin cells and oil from the skin clog hair follicles. Typical features of the condition include blackheads or whiteheads, pimples, oily skin, and possible scarring.

Yes, Acne Medication companies are profiled in the report.

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

Acne Medication Market

Global Opportunity Analysis and Industry Forecast, 2019-2027